Overview
Clouds of Care accelerates the adoption of objective neurophysiological endpoints through a multimodal AI-powered biomarker platform across CNS indications. The company offers clinical development services to de-risk and streamline CNS clinical trials, and operates as a curated network of solutions connected via one platform. They specialize in EEG-based biomarker services for rare and complex CNS clinical trials, with particular focus on epilepsy and developmental and epileptic encephalopathies.
Leadership & org chart
In the news
- Momentum is building. Meet Steffanie J. Bristol, representing Clouds of Care at LSX Boston, September 22–25, and learn how we are building the category-defining neurophysiology and biomarker platform for CNS clinical development and care.
- 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂, #𝗘𝗘𝗖𝟮𝟬𝟮𝟲! 𝗙𝗼𝘂𝗿 𝗱𝗮𝘆𝘀 𝗶𝗻 𝗔𝘁𝗵𝗲𝗻𝘀. 𝗦𝗼𝗺𝗲𝘄𝗵𝗲𝗿𝗲 𝗶𝗻 𝘁𝗵𝗮𝘁 𝗹𝗮𝗯𝘆𝗿𝗶𝗻𝘁𝗵 𝗼𝗳 𝗮 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗵𝗮𝗹𝗹, 𝗜 𝘁𝗵𝗶𝗻𝗸 𝘄𝗲 𝗳𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝗲𝘅𝗶𝘁. 𝗜𝘁 𝘄𝗮𝘀 𝘄𝗼𝗿𝘁𝗵 𝗲𝘃𝗲𝗿𝘆 𝘄𝗿𝗼𝗻𝗴 𝘁𝘂𝗿𝗻! ♥️ What stayed with us was the amount of hopeful news. Across gene therapy, ASOs, and precision pharmacology, several programmes reported encouraging results; different modalities, same direction of travel, in populations that had limited to no options a few years
- 𝗪𝗘'𝗥𝗘 𝗟𝗜𝗩𝗘 𝗜𝗡 𝗔𝗧𝗛𝗘𝗡𝗦! 🇬🇷𝗕𝗼𝗼𝘁𝗵 #52 at EEC Doors are open at the 16th European Epilepsy Congress, 5–9 September. Our stand is ready, the team is on the floor, and we'd love to meet you! ✅ Curious how 𝗲𝗹𝗲𝗰𝘁𝗿𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆 can reveal 𝗱𝗶𝘀𝗲𝗮𝘀𝗲-𝗺𝗼𝗱𝗶𝗳𝘆𝗶𝗻𝗴 𝗲𝗳𝗳𝗲𝗰𝘁𝘀 that seizure count alone will never show? ✅ Looking to build 𝗘𝗘𝗚/𝗘𝗥𝗣/𝗣𝗦𝗚 𝗲𝗻𝗱𝗽𝗼𝗶𝗻𝘁𝘀 into your protocol, with 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 from design through readout? ✅ Weighing up 𝗮𝘁-𝗵𝗼𝗺𝗲 𝘃𝘀
- 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐢𝐬𝐨𝐫𝐲 𝐁𝐨𝐚𝐫𝐝 𝐛𝐞𝐡𝐢𝐧𝐝 𝐂𝐥𝐨𝐮𝐝𝐬 𝐨𝐟 𝐂𝐚𝐫𝐞.🔥 Building a multimodal biomarker platform for CNS drug development, starting with electrophysiology, means our science has to withstand the toughest scrutiny in neurology. We are grateful to work together with extraordinary independent experts whose combined experience spans EEG science, rare neurology, neurodegeneration, medical device innovation, and regulatory drug development:
- 𝐉𝐮𝐬𝐭 5 𝐝𝐚𝐲𝐬 𝐭𝐨 𝐄𝐄𝐂 2026! 🇬🇷 We are heading to Athens for 𝘵𝘩𝘦 16𝘵𝘩 𝘌𝘶𝘳𝘰𝘱𝘦𝘢𝘯 𝘌𝘱𝘪𝘭𝘦𝘱𝘴𝘺 𝘊𝘰𝘯𝘨𝘳𝘦𝘴𝘴 (𝘌𝘌𝘊 2026), 5–9 𝘚𝘦𝘱𝘵𝘦𝘮𝘣𝘦𝘳, one of the biggest gatherings on the calendar and always a great pulse-check on where the field is heading. One theme we expect to see front and center again this year: EEG has moved far beyond seizure detection. It is now driving richer insights into epileptiform activity, sleep macro- and micro-architecture, cognitive function toward target engagement,
- We’ll be at LSI Europe. Join us as our CEO, Gregor, is presenting in Barcelona, October 1. looking forward to connecting with investors, strategic partners, and biopharma leaders.
- Excited to share that I'll be presenting CLOUDS OF CARE at LSI Europe '26 in Barcelona, September 28 – October 1. 🧠 CLOUDS OF CARE brings a validated neurophysiology platform that turns raw EEG data into reliable measures of brain function, giving drug developers and clinicians more precise, actionable insight into brain health. As we scale that platform and deepen its role in drug development, we’re looking forward to connecting with investors, strategic partners, and biopharma leaders in Barcelona. I'll be presenting on
- 𝐂𝐥𝐨𝐮𝐝𝐬 𝐨𝐟 𝐂𝐚𝐫𝐞 𝐢𝐬 𝐩𝐫𝐨𝐮𝐝 𝐭𝐨 𝐣𝐨𝐢𝐧 𝐂𝐨𝐦𝐩𝐨𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐌𝐮𝐥𝐭𝐢𝐦𝐨𝐝𝐚𝐥 𝐄𝐧𝐝𝐩𝐨𝐢𝐧𝐭𝐬 𝐟𝐨𝐫 𝐏𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞, 𝐚 𝐧𝐞𝐰 𝐢𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞 𝐥𝐞𝐝 𝐛𝐲 Digital Medicine Society (DiMe) 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐭𝐡𝐞 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐌𝐞𝐚𝐬𝐮𝐫𝐞𝐦𝐞𝐧𝐭 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 (𝐃𝐀𝐓𝐀𝐜𝐜), 𝐢𝐧 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 FDA, 𝐭𝐨 𝐦𝐚𝐤𝐞 𝐩𝐢𝐯𝐨𝐭𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐟𝐨𝐫 𝐫𝐚𝐫𝐞 𝐩𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜
Alumni
Tom Van SteenkisteHead of Development
Something wrong or missing? Send an update. Fixed within 24 hours.